Johnson and Johnson

An AI imaging firm says Johnson & Johnson stole its tech. Execs on both sides are expected to… Yahoo! UK & Ireland09:48
American pharmaceutical companies still aren’t paying tax in the U.S. Council on Foreign Relations17:20
Legend Biotech and J&J invest 150m dollars in expansion of production in Ghent Belga News Agency16:47
Johnson & Johnson CEO Joaquin Duato takes a 14% pay cut to $24.3M FiercePharma15:31
J&j tells 3rd circ. No price impact in talc concealment suit Law36001:09
J&J faces biometric privacy lawsuit in US over Neutrogena Skin360 facial-scanning service cosmeticsbusiness.com12:24
Johnson & Johnson investors defend class action over reports of asbestos-laden baby powder Courthouse News23:27

Latest News

In the last 4 hours

FDA Grants Fast Track Review To Johnson & Johnson's Nipocalimab For Autoimmune Disorder That Affects Tears, Saliva Benzinga16:39

In the last 6 hours

Factor XI Inhibitors: The Future of Anticoagulation Pharmacy Times15:57

In the last 8 hours

Cancer-Focused Nanobiotix Adjusts $2.7 Billion Johnson & Johnson Agreement To Strengthen Finances And Relieve Funding… Benzinga13:05

J&J Receives FDA Fast Track Designation For Nipocalimab For Moderate-to-Severe Sjögren's Disease RTT News12:20

Earlier today

Your health can't wait: Connecting Houston communities to care Aspen Daily News, Colorado08:44

Got $300? Buy These 3 Top Dividend Stocks and Never Look Back. The Motley Fool08:37

Yesterday

Nanobiotix Strengthens Financial Position Through Amendment of Global Licensing Agreement for JNJ-1900 (NBTXR3) and… GlobeNewswire (Press Release)20:24 17-Mar-25

In the last 7 days

Kenvue + Johnson & Johnson: I Choose To Own The Whole 'Humpty Dumpty' Seeking Alpha18:43 16-Mar-25

An AI imaging firm says Johnson & Johnson stole its tech. Execs on both sides are expected to… Yahoo! UK & Ireland09:48 15-Mar-25

Court Dismisses Religious Discrimination Lawsuit Against Johnson & Johnson Over COVID-19 Testing Lawyer Monthly17:54 14-Mar-25

American Pharmaceutical Companies Still Aren’t Paying Tax in the U.S. Council on Foreign Relations17:20 14-Mar-25

Legend Biotech and J&J invest 150m dollars in expansion of production in Ghent Belga News Agency16:47 14-Mar-25

Christian Ex-J&J Worker Loses Job Bias Appeal Over Covid Testing Bloomberg Law15:31 14-Mar-25

Johnson & Johnson Faces Lawsuit Over Neutrogena Skin360 Service Lawyer Monthly13:00 14-Mar-25

J&J Unit Drops Noncompete Suit Against Ex-Marketing Exec Law36020:46 13-Mar-25

FDA grants 510(k) clearance for J&J MedTech’s Monarch Quest Verdict Medical Devices11:41 13-Mar-25

Lilly, J&J Boosted Spending on Executive Security After UnitedHealth Shooting Insurance Journal05:23 13-Mar-25

Johnson & Johnson CEO Joaquin Duato takes a 14% pay cut to $24.3M FiercePharma15:31 12-Mar-25

Bispecific Antibody Market Opportunity, Drug Dosage, Patent, Price, Sales & Clinical Trials Insight 2030: New Report… GlobeNewswire (Press Release)12:52 12-Mar-25

J&J faces biometric privacy lawsuit in US over Neutrogena Skin360 facial-scanning service cosmeticsbusiness.com12:24 12-Mar-25

Johnson & Johnson MedTech Announces Clearance of MONARCHTM QUEST for Enhanced Robotic-Assisted Bronchoscopy Johnson & Johnson (Press Release)12:03 12-Mar-25

J&J Tells 3rd Circ. No Price Impact In Talc Concealment Suit Law36001:09 12-Mar-25

Johnson & Johnson investors defend class action over reports of asbestos-laden baby powder Courthouse News23:27 11-Mar-25

Ex-J&J Atty Says She Was Fired For Making Ethics Complaint Law36019:43 11-Mar-25

J&J Can’t Evade Biometric Suit Over At-Home Skin Care Face Scans Bloomberg Law17:51 11-Mar-25

J&J and Protagonist’s icotrokinra scores in Phase IIb UC study Clinical Trials Arena14:44 11-Mar-25

Investigational plaque psoriasis treatments show promise in late-stage trials European Pharmaceutical Review12:47 11-Mar-25

J&J/Protagonist’s icotrokinra shows promise in phase 3 plaque psoriasis programme PMLiVE12:29 11-Mar-25

J&J abandons work with Genmab on Darzalex successor pharmaphorum12:25 11-Mar-25

Recent Controlled Study Validates the Significantly Lower Hemolysis of the SHA Whisper Device… PR Newswire (Press Release)11:06 11-Mar-25

In the last month

How pharmaceutical companies are training their workers on AI Business Insider19:40 10-Mar-25

Icotrokinra Demonstrates Meaningful Skin Clearance in Moderate-to-Severe Plaque Psoriasis Pharmacy Times18:10 10-Mar-25

Zacks Investment Ideas feature highlights: Gilead Sciences and Johnson & Johnson Barchart16:28 10-Mar-25

Zacks Investment Ideas feature highlights: Coca-Cola, Philip Morris and Johnson & Johnson Barchart16:28 10-Mar-25

Genmab Reveals J&J's Decision Not To Advance Hexabody-CD38, Shares Fall RTT News15:17 10-Mar-25

Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38 GlobeNewswire (Press Release)14:17 10-Mar-25

Johnson & Johnson Reports Positive Topline Results For Icotrokinra In Ulcerative Colitis RTT News12:37 10-Mar-25

Icotrokinra meets primary endpoint of clinical response in ulcerative colitis study and shows potential to transform… Johnson & Johnson (Press Release)12:02 10-Mar-25

Johnson & Johnson MedTech Showcases New Era of Digital Orthopaedics at AAOS 2025 PR Newswire (Press Release)12:01 10-Mar-25

J&J shows its confidence in oral IL-23 drug for psoriasis pharmaphorum11:30 10-Mar-25

Icotrokinra results show potential to set a new standard of treatment in plaque psoriasis PR Newswire (Press Release)14:01 8-Mar-25

J&J scraps depression testing for potential blockbuster drug BioPharma Dive17:22 7-Mar-25

Pfizer Vs. Johnson & Johnson: Who's The Better Bargain For Investors Seeking Alpha16:48 7-Mar-25

J&J drops Phase III MDD programme due to lack of efficacy Clinical Trials Arena16:26 7-Mar-25

3 Dividend Kings Shaking Off Market Woes Zacks15:34 7-Mar-25

Cosmetic Surgery Market Forecast Report and Company Analysis 2025-2033 Featuring AbbVie, Cutera, Sientra, Bausch… GlobeNewswire (Press Release)12:29 7-Mar-25

J&J’s Lazcluze/Rybrevant combination granted MHRA approval for lung cancer PMLiVE12:25 7-Mar-25

One of J&J's blockbuster depression hopes has flamed out pharmaphorum11:58 7-Mar-25

Johnson & Johnson Statement on VENTURA Program Johnson & Johnson (Press Release)22:17 6-Mar-25

Pfizer appoints former J&J executive to lead development of obesity medicines KELO TV19:57 6-Mar-25

IVE, PG, JNJ, JPM: Large Inflows Detected at ETF Nasdaq16:38 6-Mar-25

Johnson & Johnson to Host Investor Conference Call on First-Quarter Results Johnson & Johnson (Press Release)21:32 5-Mar-25

Former Limerick hurler is 'a totally different man' after sustaining work injury, court told TheJournal.ie20:36 5-Mar-25

Ex-Limerick hurler is 'totally different man' after workplace accident, wife tells court BreakingNews.ie19:42 5-Mar-25

FDA approves first generics of anticoagulant Xarelto pharmaphorum10:49 5-Mar-25

Ex-Limerick hurler seeking damages over workplace injury cycled distances of up to 105km after… Irish Mirror05:17 5-Mar-25

Ex-hurler seeking damages over workplace injury cycled distances of up to 105km after operation Irish Mirror05:00 5-Mar-25

Former hurler seeking damages over workplace injury cycled up to 105km after surgery BreakingNews.ie22:05 4-Mar-25

Buy Johnson & Johnson (JNJ) Stock for Higher Highs? Zacks21:39 4-Mar-25

Johnson & Johnson Announces Darren Snellgrove as Vice President, Investor Relations Johnson & Johnson (Press Release)21:18 4-Mar-25

Court told ex-hurler seeking damages over workplace injury later cycled distances up to 105K TheJournal.ie20:01 4-Mar-25

Ex-Limerick hurler Mark Keane cycled 105km after operation, workplace injury case told Irish Examiner18:32 4-Mar-25

Former Limerick hurler seeking damages over workplace injury cycled up to 105km after operation, court hears The Irish Times18:21 4-Mar-25

Johnson & Johnson DARZALEX receives positive CHMP opinion European Pharmaceutical Manufacturer14:11 4-Mar-25

Johnson & Johnson Just Paid Investors: Here's How Much They Got 24/7 Wall St.13:55 4-Mar-25

Shockwave Medical Launches Novel Forward Intravascular Lithotripsy Platform in U.S. to Transform Treatment of… Johnson & Johnson (Press Release)13:01 4-Mar-25

J&J receives three CHMP recommendations for immunology and oncology indications PMLiVE12:35 4-Mar-25

Noteworthy Monday Option Activity: AAOI, JNJ, ABT Nasdaq21:01 3-Mar-25

Johnson & Johnson Pitches Final Arguments to Approve $10B Talc Bankruptcy Plan Law.com20:10 3-Mar-25

3rd Circ. Preview: Litigation Funder, J&J Seek Relief In March Law36018:27 3-Mar-25

The future of immunology Johnson & Johnson (Press Release)12:00 3-Mar-25

3 Top High-Yield Dividend Stocks I Plan to Buy in March for More Passive Income The Motley Fool12:43 2-Mar-25

3 Dividend Stocks That Are No-Brainer Buys Right Now The Motley Fool10:55 1-Mar-25

J&J Talc Spinoff Wraps Two-Week Chapter 11 Trial Law36003:52 1-Mar-25

J&J Spars With Foes of $9 Billion Talc Cancer Plan as Trial Ends Bloomberg Law02:10 1-Mar-25

Former senior Limerick hurler tells High Court he was 'mentally destroyed' by work injury TheJournal.ie20:22 28-Feb-25

Former Limerick hurler tells High Court he was 'emasculated and mentally destroyed' by work injury BreakingNews.ie19:05 28-Feb-25

Former Limerick hurler felt 'mentally destroyed' due to injuries at Johnson & Johnson factory Irish Examiner18:13 28-Feb-25

Is Johnson & Johnson Stock Underperforming the Dow? Barchart17:49 28-Feb-25

2 Boring Safe-Play Stocks to Protect Against Market Turmoil Investing.com UK14:51 28-Feb-25

Tremfya® (guselkumab) receives positive Chmp opinion for treatment of adult patients with moderately to severely active … GlobeNewswire (Press Release)13:44 28-Feb-25

Johnson & Johnson’s Darzalex® (daratumumab) subcutaneous-based regimen receives positive Chmp opinion for patients with … GlobeNewswire (Press Release)13:03 28-Feb-25

Mayo local receives prestigious award for his 'academic excellence' The Mayo News12:33 28-Feb-25

Johnson & Johnson has announced data from Phase 3 study European Pharmaceutical Manufacturer11:42 28-Feb-25

GE HealthCare announces Will Song as new president and CEO in China Verdict Medical Devices11:04 28-Feb-25

J&J Talc Settlement Blasted by Ex-FDA Head Over Asbestos Testing Bloomberg Law20:58 27-Feb-25

Former Limerick hurler sues Johnson & Johnson over injuries at work The Irish Times19:30 27-Feb-25

Former Limerick hurler takes action against Johnson & Johnson over injuries at work BreakingNews.ie18:50 27-Feb-25

Seizures Pipeline Insight Analysis Report, Competitive Analysis of Eisai, Novartis, Johnson & Johnson, and Neurelis GlobeNewswire (Press Release)15:17 27-Feb-25

GE HealthCare names J&J veteran Song as new China chief SHINE11:30 27-Feb-25

GE HealthCare names new president and CEO for China biz BioSpectrum Asia10:17 27-Feb-25

GE HealthCare names new president and CEO, China Business Wire (Press Release)07:08 27-Feb-25

Johnson & Johnson (JNJ) Shares Cross 3% Yield Mark Nasdaq20:22 26-Feb-25

Catheter Market Global Report and Company Analysis 2025-2033 Featuring Abbott Laboratories, BD and Co, Boston… GlobeNewswire (Press Release)16:13 26-Feb-25

Abdo partners with J&J Vision on CPD Optician Online15:11 26-Feb-25

J&J’s shares positive results for subcutaneous Tremfya in phase 3 ulcerative colitis trial PMLiVE12:21 26-Feb-25

3 "Forever Stocks" You Can Buy and Hold for Decades Entrepreneur Magazine00:44 26-Feb-25

J&J Says Samsung Is Breaking Deal Over Stelara Biosimilar Law36022:54 25-Feb-25

J&J sues Samsung Bioepis over ‘surreptitious’ breach of Stelara biosimilar contract Pharmaceutical Technology22:44 25-Feb-25

Kansas Hospital Sues HHS Over J&J Audit in Discount Drug Program Bloomberg Law20:30 25-Feb-25

J&J Talc Unit Seeks Kirkland as Special Counsel in Bankruptcy Bloomberg Law18:59 25-Feb-25

Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors GlobeNewswire (Press Release)12:37 25-Feb-25

J&J’s potential neurovascular exit: implications for market dynamics Verdict Medical Devices11:23 25-Feb-25

Jones Whyte leads group action against Johnson & Johnson in Scotland Scottish Legal News10:29 25-Feb-25

ITCI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intra-cellular… Business Wire (Press Release)04:23 25-Feb-25

J&J Sues Samsung Unit Alleging Improper Stelara Biosimilar Copy Bloomberg Law23:59 24-Feb-25

J&J sues Samsung Bioepis over contract breach for Stelara biosimilar Yahoo! US22:39 24-Feb-25

Advancing surgical tools and cancer treatments: Helping build a healthier S’pore The Straits Times20:02 24-Feb-25

90% of Gen Z Tie Clear Vision to Self-confidence, According to Acuvue Women's Wear Daily15:11 24-Feb-25

2 Very Healthy High-Yield Dividend Stocks to Buy for a Safe and Growing Passive Income Stream The Motley Fool12:39 24-Feb-25

J&J’s fully subcutaneous Tremfya shows 27.6% clinical remission in UC Clinical Trials Arena16:35 21-Feb-25

Teva Pharma and Alvotech launch biosimilar to J&J's Stelara in US KELO TV13:18 21-Feb-25

TREMFYA® (guselkumab) subcutaneous (SC) induction data support potential to be the first and… PR Newswire (Press Release)12:01 21-Feb-25

$3.77 Bn Surgical Meshes Market Opportunities and Strategies to 2034: Medtronic Leads the Fragmented Market, Followed… GlobeNewswire (Press Release)09:44 21-Feb-25

Keen bid for corporates after Johnson & Johnson hit Global Capital20:15 20-Feb-25

view more headlines

18 Mar 16:39

About our Johnson & Johnson news

Latest news on Johnson & Johnson, the American multinational pharmaceutical, known for developing healthcare, pharmaceuticals, and consumer products. Stay updated on stories about their pioneering medical advancements, including vaccines, treatments, and medical devices. Explore insights into the company’s financial performance, share prices, leadership changes, and global strategies.

Johnson and Johnson

Latest News

About our Johnson & Johnson news

Pharmaceuticals Top Stories

UK Top Stories

World Top Stories